The use of analgesics in patients with asthma

Drug Safety

Volumn 24, Issue 11, 2001, Pages 829-841

  Levy, S ^a   Volans, G ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; KETOROLAC; LEUKOTRIENE; LOXOPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PARACETAMOL; PIROXICAM; PROSTAGLANDIN SYNTHASE; ROFECOXIB;

ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; CROSS ALLERGY; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG USE; ENZYME INHIBITION; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY FUNCTION; REVIEW;

EID: 0034773907     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124110-00004     Document Type: Review

References (61)

1. Frequent paracetamol use and asthma in adults
2. Paracetamol and asthma
3. Paracetamol and asthma
4. Paracetamol and asthma
5. Paracetamol and asthma
6. Paracetamol and asthma
7. Paracetamol and asthma
8. Paracetamol and asthma
9. The aspirin disease
10. Clinical features and diagnosis of aspirin induced asthma
11. Long term prognosis for near fatal asthma: A 6 year follow up study of 145 asthmatic patients who underwent mechanical ventilation fore a near fatal attack of asthma
12. Natural history of aspirin-induced asthma
13. Asthma in children and ASA intolerance
14. Aspirin intolerance II: A prospective study in an atopic and normal population
15. Prevalence of asthma, aspirin intolerance, nasal polyposis and COAD in a population based study
16. Aspirin induced asthma: Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymatic preparations
17. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects
18. Prevalence and etiology of asthma
19. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
20. Rates of sensitivity reactions to aspirin: Problems in interpreting the data
21. Aspirin intolerance in chronic childhood asthma detected by oral challenge
22. Reye syndrome update
23. Aspirin and other anti-inflammatory drugs
24. Asthma morbidity following short-term use of acetaminophen and ibuprofen in asthmatic children
25. Flurbiprofen (ansaid) cross sensitivity in an aspirin sensitive asthmatic patient
26. A case of aspirin-induced asthma due to ketoprofen adhesive agent
27. Loxoprofen: Another NSAID associated with acute asthmatic death
28. Ketorolac-induced bronchospasm in an aspirin-intolerant patient
29. Asthma death induced by ibuprofen
30. Severe asthma attacks precipitated by NSAIDS
31. Asthma caused by topical application of ketorolac
32. Exacerbation of asthma by topical diclofenac
33. Severe asthmatic reaction to contraindicated anti-inflammatory drug
34. Ibuprofen and asthma
35. Asthma death due to ibuprofen
36. Acetaminophen induced asthma in a patient with aspirin idiosyncrasy
37. Cross sensitivity with acetaminophen in aspirin sensitive subjects with asthma
38. Non steroid drug selectivity for cycloxygenase-1 correlate with human gastrointestinal toxicity: A full in vitro analysis
39. Nimesulide in the treatment of patients intolerant to aspirin and other NSAIDs
40. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
41. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX 2) in asthmatic airways and its cellular distribution in aspirin sensitive asthmatics
42. Inhibition of prostaglandin synthase in brain explains the antipyretic activity of paracetamol
43. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
44. Leukotrienes and aspirin induced asthma
45. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma
46. Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics
47. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin sensitive asthmatic subjects
48. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses
49. Over expression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin intolerant asthma
50. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma
51. Antileukotriene agents and aspirin-sensitive asthma: Are we removing the second bassoonist or skating to where the puck is gonna be?
52. Desensitisation of aspirin sensitive asthmatics: A therapeutic alternative?
53. Aspirin desensitization in aspirin sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period
54. Desensitisation in aspirin induced asthma
55. Management of aspirin sensitive rhinosinusitis-asthma syndrome; what role for aspirin desensitization?
56. Urinary leukotriene E4 in bronchial asthma
57. Leukotriene C synthase promoter polymorphism and risk of aspirin induced asthma
58. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma
59. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma
60. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma
61. Asthma and analgesics: A treatment algorithm